HomeDiscussions$LLY.TSX Q2 '26 Earnings Results & Recap
Eli Lilly and Company updated its 2026 full-year revenue guidance to a range of $85.0 billion to $87.0 billion, while maintaining its non-GAAP EPS guidance range at $35.50 to $36.50.
Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
$LLY.TSX Q2 '26 Earnings Results & Recap
Eli Lilly and Company updated its 2026 full-year revenue guidance to a range of $85.0 billion to $87.0 billion, while maintaining its non-GAAP EPS guidance range at $35.50 to $36.50.